Abstract
Harmine (HM), a β-carboline alkaloid extracted from the seeds of Peganum harmala L., has been reported to have antitumor effects. However, the effects and mechanism of action of HM in human gastric cancer cells remain unclear. This study evaluated the antitumor effects of HM in human gastric cancer in vitro. The in vitro cytotoxicity test indicated that HM inhibits gastric cancer cell viability in a dose- and time-dependent manner. Intracellular ROS production was measured using the fluorescent substrate DCFH-DA. The percentage of apoptotic cells was determined by flow cytometry analysis and DAPI staining. Western blot analysis showed the expression of p-AKT, Bcl-2, Bax and caspase-3 in SGC-7901 cells treated with various agents. We demonstrated that HM induces gastric cancer cell apoptosis through the ROS-mediated PI3K/AKT signaling pathway. Therefore, data from this study not only confirm the potential of HM for the treatment of gastric cancer but also offer a promising anticancer therapeutic strategy for treating gastric cancer.
Keywords: Anticancer, apoptosis, gastric cancer, harmine, reactive oxygen species.
Graphical Abstract
Current Signal Transduction Therapy
Title:Harmine Induces Gastric Cancer Cell Apoptosis through the ROSmediated PI3K/AKT Signaling Pathway
Volume: 10 Issue: 2
Author(s): Qingqing Ding, Zhuoyun Wang, Ke Ma and Qi Chen
Affiliation:
Keywords: Anticancer, apoptosis, gastric cancer, harmine, reactive oxygen species.
Abstract: Harmine (HM), a β-carboline alkaloid extracted from the seeds of Peganum harmala L., has been reported to have antitumor effects. However, the effects and mechanism of action of HM in human gastric cancer cells remain unclear. This study evaluated the antitumor effects of HM in human gastric cancer in vitro. The in vitro cytotoxicity test indicated that HM inhibits gastric cancer cell viability in a dose- and time-dependent manner. Intracellular ROS production was measured using the fluorescent substrate DCFH-DA. The percentage of apoptotic cells was determined by flow cytometry analysis and DAPI staining. Western blot analysis showed the expression of p-AKT, Bcl-2, Bax and caspase-3 in SGC-7901 cells treated with various agents. We demonstrated that HM induces gastric cancer cell apoptosis through the ROS-mediated PI3K/AKT signaling pathway. Therefore, data from this study not only confirm the potential of HM for the treatment of gastric cancer but also offer a promising anticancer therapeutic strategy for treating gastric cancer.
Export Options
About this article
Cite this article as:
Ding Qingqing, Wang Zhuoyun, Ma Ke and Chen Qi, Harmine Induces Gastric Cancer Cell Apoptosis through the ROSmediated PI3K/AKT Signaling Pathway, Current Signal Transduction Therapy 2015; 10 (2) . https://dx.doi.org/10.2174/1574362410666150625190713
DOI https://dx.doi.org/10.2174/1574362410666150625190713 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Dilemma of Functional Genomics: Count the Chickens or Study their Eggs ?
Current Genomics Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
Current Pharmaceutical Design Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
Current Vascular Pharmacology Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo
Current Cancer Drug Targets Cancer Therapy: Targeting Mitochondria and other Sub-cellular Organelles
Current Pharmaceutical Design Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets Genetic Instability Influences Drug Response in Cancer Cells
Current Drug Targets CEACAM1 in Malignant Melanoma: A Diagnostic and Therapeutic Target
Current Topics in Medicinal Chemistry Azole Antimycotics - A Highway to New Drugs or a Dead End?
Current Medicinal Chemistry Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology
Current Drug Metabolism Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting
Current Molecular Pharmacology The Role of Phenolic Compounds in the Fight against Cancer – A Review
Anti-Cancer Agents in Medicinal Chemistry Current Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods
Current Medicinal Chemistry Nongenomic Actions of Retinoids: Role of Nur77 and RXR in the Regulation of Apoptosis and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Patented Bioavailability Enhancement Techniques of Silymarin
Recent Patents on Drug Delivery & Formulation Dimer and Tetramer of Gallic Acid: Facile Synthesis, Antioxidant and Antiproliferative Activities
Letters in Drug Design & Discovery Third Generation Radiopharmaceuticals for Imaging and Targeted Therapy
Current Pharmaceutical Analysis Steroid Receptor Ligands for Breast Cancer Targeting: An Insight into Their Potential Role As Pet Imaging Agents
Current Medicinal Chemistry The Human L1 Element: A Potential Biomarker in Cancer Prognosis, Current Status and Future Directions
Current Molecular Medicine Patent Selections:
Recent Patents on Drug Delivery & Formulation